+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Proteomics Market - Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery, Others), End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • ID: 5397196
  • Report
  • July 2021
  • Region: Global
  • 200 pages
  • Azoth Analytics
UP TO OFF
until Dec 31st 2021

The Global Proteomics Market is estimated at USD 3.49 Billion in the year 2020, growing at a CAGR of 7% for the period spanning 2021-2026. Proteomics market growth is driven by rise in popularity of personalized medicines, surge in R&D expenditure, and technological advancements associated with proteomics components. Moreover, high costs associated with components and dearth of skilled professionals hamper the market growth. Conversely, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities for the proteomics market growth. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2026. However, the market is constrained by strict regulatory norms and the high cost of the instruments. In the human body, proteins play an essential role in the biological activities and hence the measurement of its expression levels in healthy and diseased individuals should uncover novel scientific insights. Although proteomics markets has been in existence for more than 25 years with initially immunoassay and ELISA market and later mass spec technologies that help stabilize ions and currently the proteomics high-plex market that are in initial stages but expected to see major expansion. The growing prominence of nano proteomics, development of personalized proteomics for precision health, and the high growth opportunities in emerging countries are expected to offer potential growth opportunities to market players.

The Proteomics Market can be classified on the basis of Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery, Others) and End User (Hospitals, Labs and Clinics, Others).

North America held the largest market share of nearly 50.32% of the total proteomics market in 2020, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. Growth is also attributed to the increasing investments in the development of structure-based drug design, growing research in the field of proteomics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.

Scope of the Report:

  • The report presents the analysis of Proteomics market for the historical period 2016-2020 and forecast period of 2021-2026.
  • The report analyses the Proteomics Market by value (USD Million).
  • The report analyses the Proteomics Market by Component (Instruments, Reagents, Services)
  • The report analyses the Proteomics Market by Application (Clinical Diagnostic, Drug Discovery, Others).
  • The report analyses the Proteomics Market End User (Hospitals, Labs and Clinics, Others).
  • The Global Proteomics Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA) By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India, South Korea).
  • The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Component, By Application, By End User.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck KGaA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher, QIAGEN, Agilent Tecnologies, Bruker Corporation, GE Healthcare, Eurofins Scientific, Wuxi APPTECC, Promega Corporation.

Key Target Audience:

  • Pharmaceutical and Healthcare Companies
  • Biotechnology Companies
  • Consulting and Advisory Firms
  • Consulting Firms
  • Government and Policy Makers
  • Regulatory Authorities
Note: Product cover images may vary from those shown
1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations
2.1 Development of health information technology
2.2 Focus on improving test utilization
2.3 Program for functional structural biology research

3. Proteomics Market: Product Outlook

4. Global Proteomics Market: Sizing and Forecast
4.1 Global Proteomics Market Size, By Value, Year 2016-2026

5. Global Proteomics Market Segmentation - By Component, By Application, and By End User
5.1 Competitive Scenario of Global Proteomics Market: By Component
5.1.1 Instruments - Market Size and Forecast (2016-2026)
5.1.2 Reagents - Market Size and Forecast (2016-2026)
5.1.3 Services - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Proteomics Market: By Application
5.2.1 Clinical Diagnostic - Market Size and Forecast (2016-2026)
5.2.2 Drug Discovery - Market Size and Forecast (2016-2026)
5.2.3 Others - Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Proteomics Market: By End User
5.3.1 Hospitals - Market Size and Forecast (2016-2026)
5.3.2 Labs and Clinics - Market Size and Forecast (2016-2026)
5.3.3 Others - Market Size and Forecast (2016-2026)

6.Global Proteomics Market: Regional Analysis
6.1 Competitive Scenario of Global Proteomics Market: By Region

7. North America Proteomics Market: Segmentation (By Component, By Application, and By End User)
7.1 North America Proteomics Market: Size and Forecast (2016-2026), By Value
7.2 North America Proteomics Market - Prominent Companies
7.3 Market Segmentation By Component (Instruments, Reagents and Services)
7.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
7.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
7.6 North America Proteomics Market: Country Analysis
7.7 Market Opportunity Chart of North America Proteomics Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Proteomics Market: By Country
7.9 United States Proteomics Market: Size and Forecast (2016-2026), By Value
7.10 United States Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
7.11 Canada Proteomics Market: Size and Forecast (2016-2026), By Value
7.12 Canada Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)

8. Europe Proteomics Market: Segmentation (By Component, By Application, and By End User)
8.1 Europe Proteomics Market: Size and Forecast (2016-2026), By Value
8.2 Europe Proteomics Market - Prominent Companies
8.3 Market Segmentation By Component (Instruments, Reagents and Services)
8.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
8.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
8.6 Europe Proteomics Market: Country Analysis
8.7 Market Opportunity Chart of Europe Proteomics Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Proteomics Market: By Country
8.9 Germany Proteomics Market: Size and Forecast (2016-2026), By Value
8.10 Germany Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.11 United Kingdom Proteomics Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.13 France Proteomics Market: Size and Forecast (2016-2026), By Value
8.14 France Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.15 Italy Proteomics Market: Size and Forecast (2016-2026), By Value
8.16 Italy Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)

9. Asia Pacific Proteomics Market: Segmentation (By Component, By Application, and By End User)
9.1 Asia Pacific Proteomics Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Proteomics Market - Prominent Companies
9.3 Market Segmentation By Component (Instruments, Reagents and Services)
9.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
9.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
9.6 Asia Pacific Proteomics Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Proteomics Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Proteomics Market: By Country
9.9 China Proteomics Market: Size and Forecast (2016-2026), By Value
9.10 China Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.11 Japan Proteomics Market: Size and Forecast (2016-2026), By Value
9.12 Japan Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.13 India Proteomics Market: Size and Forecast (2016-2026), By Value
9.14 India Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.15 South Korea Proteomics Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)

10. Global Proteomics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends

11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Proteomics Market - By Component, 2026
11.2 Market Attractiveness Chart of Global Proteomics Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Proteomics Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Proteomics Market - By Region, 2026

12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis

13.Company Analysis
13.1 Merck KGaA
13.2 Bio-Rad Laboratories Inc.
13.3 Thermo Fisher Scientific Inc.
13.4 Danaher
13.5 QIAGEN
13.6 Agilent Technologies
13.7 Bruker Corporation
13.8 GE Healthcare
13.9 Eurofins Scientific
13.10 Wuxi APPTECC
13.11 Promega Corporation

List of Figures
  • Global Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Global Expenses (% GDP), 2015-2019
  • GDP per Capita Growth (annual %)
  • World Population 65 Years & Above (% of Total), 2015-2019
  • Global Proteomics Market- By Component Market Share, 2020 & 2026
  • Global Proteomics Market- By Instruments, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Reagents, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Services, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Application Market Share, 2020 & 2026
  • Global Proteomics Market- By Clinical Diagnostic, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Drug Discovery, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By End User Market Share, 2020 & 2026
  • Global Proteomics Market- By Hospitals, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Labs and Clinics, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
  • Global Proteomics Market- By Region Market Share, 2020 & 2026
  • North America Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • North America Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • North America Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • North America Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Market Opportunity Chart of North America Proteomics Market- By Country, By Value (Year-2026)
  • North America Proteomics Market- By Country Market Share, 2020 & 2026
  • United States Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • United State Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • United State Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • United State Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Canada Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Canada Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Canada Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • Canada Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Europe Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Europe Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Europe Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • Europe Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Market Opportunity Chart of Europe Proteomics Market- By Country, By Value (Year-2026)
  • Europe Proteomics Market- By Country Market Share, 2020 & 2026
  • Germany Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Germany Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Germany Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • Germany Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • United Kingdom Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • United Kingdom Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • United Kingdom Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • United Kingdom Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • France Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • France Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • France Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Italy Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Italy Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Italy Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • Italy Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Asia Pacific Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Asia Pacific Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Asia Pacific Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • Asia Pacific Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Market Opportunity Chart of APAC Proteomics Market- By Country, By Value (Year-2026)
  • APAC Proteomics Market- By Country Market Share, 2020 & 2026
  • China Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • China Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • China Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • China Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Japan Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
  • Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Japan Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • Japan Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • Japan Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • India Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • India Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • India Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • India Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • India Proteomics Market Size, By Value, 2016-2026 (USD Million)
  • South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • South Korea Proteomics Market- By Component, By Value (USD Million), 2016-2026
  • South Korea Proteomics Market- By Application, By Value (USD Million), 2016-2026
  • South Korea Proteomics Market- By End User, By Value (USD Million), 2016-2026
  • Market Attractiveness Chart of Global Proteomics Market- By Component (Year-2026)
  • Market Attractiveness Chart of Global Proteomics Market- By Application (Year-2026)
  • Market Attractiveness Chart of Global Proteomics Market- By End User (Year-2026)
  • Market Attractiveness Chart of Global Proteomics Market- By Region (Year-2026)
  • Global Proteomics company market share (%), 2020
  • Merck KGaA Sales Revenues, 2016-2020 (USD Million)
  • Merck KGaA Gross Profit, 2016-2020 (USD Million)
  • Merck KGaA Plc Sales Revenue Split, By Business Segment (%), FY2020
  • Merck KGaA Plc Sales Revenue Split, By Geography Segment (%), FY2020
  • Bio-Rad Laboratories Inc. Sales Revenues, 2015-2019 (USD Million)
  • Bio-Rad Laboratories Inc. Net Income, 2015-2019 (USD Million)
  • Bio-Rad Laboratories Inc. sales Revenues, By Business Segment (%), FY2019
  • Bio-Rad Laboratories Inc. sales Revenue, By Geographical Segment (%), FY2019
  • Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
  • Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
  • Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
  • Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
  • Danaher Sales Revenues, 2016-2020 (USD Million)
  • Danaher Gross Profit, 2016-2020 (USD Million)
  • Danaher sales Revenues, By Business Segment (%), FY2020
  • Danaher sales Revenue, By Geographical Segment (%), FY2020
  • QIAGEN Sales Revenues, 2016-2020 (USD Million)
  • QIAGEN Gross Profit, 2016-2020 (USD Million)
  • QIAGEN sales Revenues, By Business Segment (%), FY2020
  • QIAGEN sales Revenue, By Geographical Segment (%), FY2020
  • Agilent Technologies Sales Revenues, 2016-2020 (USD Million)
  • Agilent Technologies Net Income, 2016-2020 (USD Million)
  • Agilent Technologies sales Revenues, By Business Segment (%), FY2020
  • Agilent Technologies sales Revenue, By Geographical Segment (%), FY2020
  • Bruker Corporation Sales Revenues, 2016-2020 (USD Million)
  • Bruker Corporation Gross Profit, 2016-2020 (USD Million)
  • Bruker Corporation sales Revenues, By Business Segment (%), FY2020
  • Bruker Corporation sales Revenue, By Geographical Segment (%), FY2020
  • GE Healthcare Sales Revenues, 2016-2020 (USD Million)
  • GE Healthcare sales Revenues, By Business Segment (%), FY2020
  • GE Healthcare sales Revenue, By Geographical Segment (%), FY2020
  • Eurofins Scientific Sales Revenues, 2016-2020 (USD Million)
  • Eurofins Scientific sales Revenue, By Geographical Segment (%), FY2020
  • Wuxi APPTECC Revenue, 2015-2019 (In USD Million)
  • Wuxi APPTECC Net Sales, By Operating Segment, 2019 (In %)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll